Cost-effectiveness evaluation of rapid initiation of antiretroviral therapy based on decision-tree Markov model-Reference-Cited by-同舟云学术

Cost-effectiveness evaluation of rapid initiation of antiretroviral therapy based on decision-tree Markov model

Published:2023-04-07 Issue:8 Volume:136 Page:986-988
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Guan Yuan¹²,Tang Qi¹³,Zhu Han⁴,Liu Danping³,Qi Tangkai³,Zhang Renfang³,Chen Jun³,Liu Li³,Shen Yinzhong³,Lu Hongzhou²

Affiliation:

1. School of Public Health, Fudan University, Shanghai 200032, China

2. Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, Guangdong 518100, China

3. Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China

4. Songjiang District Center for Disease Control and Prevention, Shanghai 201620, China.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference8 articles.

1. Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial;Koenig;PLoS Med,2017

2. Initiating antiretroviral therapy for HIV at a patient's first clinic visit: The rapit randomized controlled trial;Rosen;PLoS Med,2016

3. Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 data;Liu;Chin Med J,2021

4. Survival analysis on HIV/AIDS MSM patients receiving antiretroviral therapy in Guizhou province (in Chinese);Chen;Chin J AIDS STD,2017

5. Effect of LPV/r based second-line ART after failure of the first-line ART in Yunnan province (in Chinese);Li;Chin J AIDS STD,2017